Capillary C4d and kidney allograft outcome in relation to morphologic lesions suggestive of antibody-mediated rejection

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 8, 2015, Pages 1435-1445

  Kikić, Željko ^a   Kainz, Alexander ^a,b   Kozakowski, Nicolas ^a   Oberbauer, Rainer ^a,b   Regele, Heinz ^a   Bond, Gregor ^a   Böhmig, Georg A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Second Department of Medicine   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; BIOLOGICAL MARKER; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ADULT; ANTIBODY MEDIATED REJECTION; ARTERITIS; ARTICLE; CAPILLARITIS; CAPILLARY MICROTHROMBI; COMPLEMENT ACTIVATION; EMBRYO; GLOMERULITIS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERITUBULAR CAPILLARITIS; RETROSPECTIVE STUDY; SCORING SYSTEM; TRANSPLANT GLOMERULOPATHY; ADVERSE EFFECTS; ALLOGRAFT; BIOPSY; CAPILLARY; CHI SQUARE DISTRIBUTION; EVALUATION STUDY; FEMALE; GRAFT REJECTION; IMMUNOLOGY; KAPLAN MEIER METHOD; KIDNEY; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ALLOGRAFTS; BIOMARKERS; BIOPSY; CAPILLARIES; CHI-SQUARE DISTRIBUTION; COMPLEMENT ACTIVATION; COMPLEMENT C4B; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84938831502     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09901014     Document Type: Article

References (43)

1. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, KashgarianM, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3: 708-714, 2003
2. Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD,Wallace WD, Mengel M; Banff meeting report writing committee: Banff 2013 meeting report: Inclusion of c4d-negative antibodymediated rejection and antibody-associated arterial lesions.AmJ Transplant 14: 272-283, 2014
3. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmü ller G, LandW, Albert E: Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43: 1333-1338, 1993
4. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB: Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12: 574-582, 2001
5. Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB: Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 13: 779-787, 2002
6. Böhmig GA, Exner M, Habicht A, Schillinger M, Lang U, Kletzmayr J, Säemann MD, Hö rl WH, Watschinger B, Regele H: Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13: 1091-1099, 2002
7. Regele H, Böhmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S,Watschinger B, Kerjaschki D, Exner M: Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. JAmSocNephrol 13: 2371-2380, 2002
8. Sis B, Halloran PF: Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 15: 42-48, 2010
9. Loupy A,HillGS, SuberbielleC, CharronD, AnglicheauD, Zuber J, Timsit MO, Duong JP, Bruneval P, Vernerey D, Empana JP, Jouven X, Nochy D, Legendre CH: Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).AmJ Transplant 11: 56-65, 2011
10. HaasM: Pathology of C4d-negative antibody-mediated rejection in renal allografts. Curr Opin Organ Transplant 18: 319-326, 2013
11. Loupy A, Lefaucheur C, Vernerey D, Chang J, Hidalgo LG, Beuscart T, Verine J, Aubert O, Dubleumortier S, Duong van Huyen JP, Jouven X,GlotzD, Legendre C, Halloran PF: Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol 25: 2267-2277, 2014
12. DragunD,Mü ller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B,Hoebeke J, EckertD,Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G: Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352: 558- 569, 2005
13. Hirohashi T, Chase CM, Della Pelle P, Sebastian D, Alessandrini A, Madsen JC, Russell PS, Colvin RB: A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 12: 313-321, 2012
14. Valenzuela NM, McNamara JT, Reed EF: Antibody-mediated graft injury: Complement-dependent and complementindependent mechanisms. Curr Opin Organ Transplant 19: 33-40, 2014
15. Stegall MD, Diwan T, Raghavaiah S, Cornell LD, Burns J, Dean PG, Cosio FG, Gandhi MJ, Kremers W, Gloor JM: Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 11: 2405-2413, 2011
16. Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, MooneyN, Suberbielle C, Frémeaux-Bacchi V, Méjean A, Desgrandchamps F, Anglicheau D, Nochy D, Charron D, Empana JP, Delahousse M, Legendre C, Glotz D, Hill GS, Zeevi A, Jouven X: Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 369: 1215-1226, 2013
17. Farrar CA, Sacks SH: Mechanisms of rejection: Role of complement. Curr Opin Organ Transplant 19: 8-13, 2014
18. Schwarz C, Regele H, Huttary N, Wahrmann M, Exner M, Nagy-Bojarsky K, Kletzmayr J, Hö rl WH, Böhmig GA: Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. Wien Klin Wochenschr 118: 397-404, 2006
19. Bartel G,Wahrmann M, Regele H, Kiki_c Z, Fischer G, DrumlW, Mühlbacher F, Böhmig GA: Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation.AmJ Transplant 10: 2033-2042, 2010
20. Böhmig GA,WahrmannM, RegeleH, Exner M, Robl B, Derfler K, Soliman T, Bauer P, Mü llner M, Druml W: Immunoadsorption in severe C4d-positive acute kidney allograft rejection: A randomized controlled trial. Am J Transplant 7: 117-121, 2007
21. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 141: 929-937, 2004
22. Regele H, Exner M, Watschinger B, Wenter C, Wahrmann M, ö sterreicher C, SäemannMD,MersichN, Hö rlWH, Zlabinger GJ, Böhmig GA: Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 16: 2058-2066, 2001
23. Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, RegeleH, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A: Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 10: 464-471, 2010
24. Bursac Z, Gauss CH, Williams DK, Hosmer DW: Purposeful selection of variables in logistic regression. Source Code Biol Med 3: 17, 2008
25. Worthington JE, McEwen A, McWilliam LJ, Picton ML, Martin S: Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation 83: 398-403, 2007
26. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ: Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90: 68-74, 2010
27. Burns JM, Cornell LD, Perry DK, Pollinger HS, Gloor JM, Kremers WK, Gandhi MJ, Dean PG, Stegall MD: Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 8: 2684-2694, 2008
28. Sis B, Jhangri GS, Riopel J, Chang J, de Freitas DG, Hidalgo L, Mengel M, Matas A, Halloran PF: A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 12: 1168-1179, 2012
29. Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V, Salmon JE, Sis B, Zhao MH, Bruijn JA, Bajema IM: Pros and cons for C4d as a biomarker. Kidney Int 81: 628-639, 2012
30. DjamaliA, KaufmanDB, EllisTM, ZhongW,Matas A, SamaniegoM: Diagnosis andmanagement of antibody-mediated rejection: Current status and novel approaches. Am J Transplant 14: 255-271, 2014
31. Loupy A, Suberbielle-Boissel C, Hill GS, Lefaucheur C, Anglicheau D, Zuber J, Martinez F, Thervet E, Méjean A, Charron D, Duong van Huyen JP, Bruneval P, Legendre C, Nochy D: Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 9: 2561-2570, 2009
32. de Kort H, Willicombe M, Brookes P, Dominy KM, Santos- Nunez E, Galliford JW, Chan K, Taube D, McLean AG, Cook HT, Roufosse C: Microcirculation inflammation associates with outcome in renal transplant patients with de novo donorspecific antibodies. Am J Transplant 13: 485-492, 2013
33. Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9: 2520-2531, 2009
34. TroxellML,Weintraub LA, Higgins JP, Kambham N: Comparison of C4d immunostaining methods in renal allograft biopsies. Clin J Am Soc Nephrol 1: 583-591, 2006
35. Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ: C4d staining of renal allograft biopsies: A comparative analysis of different staining techniques. NephrolDial Transplant 22: 568-576, 2007
36. Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, Tolkoff-Rubin N, Cosimi AB, Colvin RB: Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 10: 2208-2214, 1999
37. Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D; Banff meeting report writing committee: Banff 2011 Meeting report: New concepts in antibody-mediated rejection. Am J Transplant 12: 563-570, 2012
38. Haas M: The significance of C4d staining withminimal histologic abnormalities. Curr Opin Organ Transplant 15: 21-27, 2010
39. Dickenmann M, Steiger J, Descoeudres B, Mihatsch M, Nickeleit V: The fate of C4d positive kidney allografts lacking histological signs of acute rejection. Clin Nephrol 65: 173-179, 2006
40. Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, MengeL M, Reeve J, Sellares J, Sis B: An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 10: 2223-2230, 2010
41. Nickeleit V, ZeilerM, Gudat F, ThielG,Mihatsch MJ:Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 13: 242-251, 2002
42. Lefaucheur C, Loupy A, Vernerey D, Duong-Van-Huyen JP, Suberbielle C, Anglicheau D, Vérine J, Beuscart T, NochyD, Bruneval P, Charron D, Delahousse M, Empana JP, Hill GS, Glotz D, Legendre C, Jouven X: Antibody-mediated vascular rejection of kidney allografts: A population-based study. Lancet 381: 313- 319, 2013
43. Meehan SM, Kremer J, Ali FN, Curley J, Marino S, Chang A, Kadambi PV: Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies. Clin JAmSoc Nephrol 6: 395-403, 2011